Evolution Global Acquisition Corp

This filing definitively launches EVOX as a publicly traded SPAC with a clear acquisition strategy targeting the critical minerals sector. Key mechanics for investors are now established: the exact trust account value ($240M or $10.00/share), the 24-month deadline (Nov. 2027), the warrant structure (11.50 strike, 5-year term from business combination), and lock-up agreements for insiders (founder shares 1yr, private warrants 30 days post-BC). Underwriter commissions include a deferred fee of up to $9.6 million. These terms are now contractually binding and cannot be changed without shareholder votes or additional conditions. This is the foundational document for tracking all future redemption deadlines, trust value, and sponsor conduct.

Establishes all terms for the IPO: trust value, deadline, redemption mechanics, sponsor economics, and conflicts. Investors can evaluate the SPAC's structure, management team, and focus on critical minerals. The low founder share price ($0.003) creates significant dilution risk and potential sponsor incentive to complete any deal.

This document is the **most informative filing this SPAC has made**. It is the full IPO prospectus, establishing all material terms for investors tracking redemption mechanics, trust value, extension provisions, sponsor conduct, and business strategy. Key mechanics: the trust will hold $175 million ($10.00 per public share). Public shareholders have the right to redeem shares for cash in connection with a business combination, regardless of how they vote. There is a 15% cap on redemptions by any shareholder acting as a group without the company's prior consent. The deadline to complete a business combination is 24 months from the closing of the IPO, with no limit on the number of extensions the company may seek (but not expected to exceed 36 months). The sponsor paid $25,000 for its founder shares ($0.004 per share), creating significant dilution for public shareholders. The document details substantial conflicts of interest: officers and directors have duties to other entities, may pursue other SPACs, and are incentivized to complete a deal due to their near-zero cost basis. Notably, CEO Stephen Silver has a prior FINRA settlement history. The target is identified as the 'critical minerals sector,' with a target enterprise value of $200 million to $1.5 billion, and the sponsor is controlled by a non-U.S. person (Stephen Silver, an Australian). This filing is material because it provides all the baseline terms for redemption calculation, trust accounting, and sponsor economics.

As reported in the Company’s amendments and acknowledged by counsel, the filing occurs during the S-1 registration comment period and does not alter the stated $10.23 trust per share or the November 12, 2027 liquidation deadline, since the entity remains in the searching/IPO phase rather than advancing a business combination transaction. The documentation does materially reframe the prospective economics and governance landscape for public shareholders. The firm attributes a fixed $400,000 out-of-pocket advisory expense to Stephen Silver and Evolution Capital Pty Ltd, noting staff requests to determine whether these payments duplicate finder’s fees and to distinguish the consulting scope from day-to-day management duties. Staff commentary further stresses that the non-managing sponsor investor’s divergent economic interests require transparent unit purchase quantities to accurately model voting influence relative to retail participants. The confirmed issuance of additional founder shares to the Sponsor adjusts the baseline dilution profile ahead of the roadshow, though precise post-offering ownership percentages remain unstated. All structural adjustments, fee acknowledgments, and dilution frameworks derive exclusively from the Company’s revised filings and the SEC staff’s enumerated compliance directives, providing pre-IPO investors with the updated sponsorship conduct and capital stack parameters that will precede any target evaluation or redemption timeline.

These SEC directives signal active regulatory scrutiny over sponsor alignment, expense drag, and capital structure transparency ahead of registration effectiveness. Disclosure requirements around the non-managing sponsor’s voting incentives and the $400,000 advisory fee structure allow investors to model how corporate development costs may subtract from distributable trust value and how founder-sponsor compensation might skew merger approval voting. Reconciling the 25% anti-dilution treatment and verifying the $92 million proceeds projection directly impacts calculated per-share economic outcomes and redemption thresholds. Because the SEC requires amended responses before advancing the filing, these comment resolutions add procedural steps that consume calendar time relative to the November 12, 2027 liquidation deadline, delaying definitive agreements, proxy materials, and potential shareholder redemption windows without altering the underlying termination date.

The filing provides current financial information and legal terms necessary for SEC effectiveness of the SPAC's IPO. It details trust account mechanics ($10.00 per share, 24-month deadline), redemption rights, sponsor compensation (founder shares at $0.004, private warrants at $1.00, $350,000 advisory fee), dilution tables (adjusted net tangible book value per share ranging from $7.25 to $0.21 depending on redemption levels), and conflict disclosures. The document is material for investors evaluating the offering.

The removal of the $240,000 administrative fee alters the projected use of proceeds that investors benchmark against trust accounts and extension timelines. The explicit linkage between mass redemptions and the stock buyback excise tax directly impacts the net economic outcome for shareholders who hold through the 2027-11-12 deadline. Deal progress indicators show the SPAC is structuring around convertible working capital facilities and acknowledging funding gaps relative to its $1.5 billion acquisition target, signaling that bridging capital remains optional rather than committed. Sponsor governance updates—the non-U.S. control designation, advisor/promoter status clarifications, and structured founder share lock-ups—provide necessary transparency on capital alignment and regulatory compliance before a business combination vote.

For investors tracking the 2027-11-12 deadline and the reported $10.23 trust-per-share balance, these comments establish that the SEC will pressure-test exit economics and sponsor alignment before permitting deal pricing or registration acceleration. The explicit mandate to quantify excise tax exposure directly maps to the redemption mechanics that determine whether public holders face diluted post-combination NAV or unexpected tax burdens. The staff’s emphasis on affiliate voting incentives, promoter classification, and non-U.S. sponsor control identifies governance friction points that shape how aggressively management may advance or defer a target. Until the amended prospectus satisfies these feedback points, transaction momentum pauses, keeping the trust intact while extending the sponsor’s search window for a $1.5 billion enterprise value asset. Publicholders should monitor subsequent amendment filings, as any shifts in working capital structures, warrant exercises, or financing plans will fundamentally alter the redemption payoff matrix well before a merger referendum.

This is the IPO registration for EVOX. The filing fully pre-sets the redemption and trust mechanics that will govern any future business combination. The trust baseline exceeds $10.00. Investors get a clear picture of sponsor economics and dilution. The focus on critical minerals is well-defined, making the search criteria transparent. The 15% redemption cap on large holders is an important structural feature that limits the ability of a single investor to block a deal. The CFO has prior SPAC experience (The Metals Company). The filing includes audited financials with a going concern qualification, which is standard for a pre-IPO SPAC.

What changed: A Form 8-K current report attached with a routine compliance exhibit—specifically, a Passive Foreign Investment Company (PFIC) Annual Statement for Class A shares. Nothing changed regarding the SPAC's redemption calendar, trust value ($10.23), merger deadline (2027-11-12), or search status. The filing addresses only U.S. federal income tax reporting obligations and does not alter the company's status, search timeline, or trust mechanics. Why it matters: The PFIC statement, prepared by Chief Financial Officer Arthur Chen on February 26, 2026, discloses that the company generated per-unit, per-day Ordinary Earnings of $0.0010056200 for the taxable period beginning 6/26/2025 and ending 12/31/2025. Both Net Capital Gains and any distributed Cash or Fair Market Value of Property are explicitly listed as NONE. As noted in the filing, these passive income figures confirm the trust account has operated without withdrawals or special distributions since the company's incorporation on 6/26/2025. The filing was signed by Chief Executive Officer Stephen Silver on March 13, 2026, and serves to enable shareholders to evaluate an optional Qualified Electing Fund (QEF) Election under Section 1295 of the Internal Revenue Code to mitigate PFIC taxation, while advising that state tax recognition of this election may vary.

What changed: 10-K (Annual Report) for Evolution Global Acquisition Corp, a blank check company (SPAC) incorporated on June 26, 2025, filed with the SEC on March 3, 2026, for the fiscal year ended December 31, 2025. This is the Company's first annual report following its IPO on November 12, 2025. This initial 10-K provides the first full financial statements post-IPO. Key items: (1) Trust account balance of $241,206,744 (comprising $240,000,000 IPO proceeds plus $1,206,744 interest) as of December 31, 2025; (2) Net loss of $4,113,235 for the period from inception (June 26, 2025) through December 31, 2025, including $5,032,916 in non-cash compensation expense from founder share grants to officers/directors; (3) No business combination target has been selected – the Company states it 'has not selected any business combination target, and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target'; (4) Sponsor purchased 4,400,000 private placement warrants at $1.00 each; underwriters purchased 2,400,000; (5) Advisory fee of $480,000 paid to Evolution Capital Pty Ltd, the managing member of the sponsor; (6) Confirmation of 24-month completion window ending November 12, 2027; (7) Disclosure of CEO Stephen Silver's prior FINRA settlements. Why it matters: Investors should note: The trust holds ~$241.2M ($10.00 per share initially, before interest). Redemption rights are available upon any business combination or amendment. No target has been identified, increasing time pressure. The sponsor's founder shares were acquired for $0.003 per share, creating significant potential dilution for public shareholders. The sponsor and underwriters hold 6.8M private placement warrants. The deadline is November 12, 2027; extension requires shareholder vote. The CEO's FINRA history (two settlements in 2016) is disclosed as a risk factor.

What changed: A Joint Acquisition Statement submitted as an exhibit to a Schedule 13G, functioning as a routine compliance acknowledgment that multiple reporting persons will share regulatory filing obligations for beneficial ownership disclosures. According to the attached exhibit text, the filing contains no information regarding EVOX’s redemption window, trust account composition, extension vote mechanics, target business combination status, or sponsor conduct. It does not amend prior ownership percentages, voting power allocations, or impose new conditional triggers tied to shareholder redemption behavior or merger approval timelines. Why it matters: The undersigned—Adage Capital Management, L.P., its general partner Adage Capital Partners LLC (represented by Managing Member Robert Atchinson), and Phillip Gross—stated that future Schedule 13G amendments would be filed jointly without separate acquisition statements, while explicitly assigning independent liability for data accuracy so that each party answers only for their own reported information. The document contains zero numerical financial metrics, customer claims, revenue projections, market sizing, strategic roadmaps, technology disclosures, partnership agreements, litigation positions, or personnel changes beyond the signatories themselves. Because it addresses only securities registration administration rather than capital event scheduling or trust management, it registers no actionable shifts for investors tracking deadline proximity, trust preservation protocols, or sponsorship accountability.

What changed: Joint Filing Agreement (Exhibit A) to a Schedule 13G beneficial ownership report. The filing records no alteration to redemption deadlines, trust value mechanics, extension procedures, business combination progress, or sponsor conduct. It solely executes a joint submission protocol under SEC Rule 13d-1(k) for four affiliated parties—Linden Capital L.P., Linden GP LLC, Linden Advisors LP, and Siu Min Wong—confirming they file collectively regarding their aggregate shareholdings in Evolution Global Acquisition Corp as documented in a December 22, 2025 statement. Why it matters: This routine compliance exhibit clarifies that the listed holders coordinate disclosure through a single representative, Saul Ahn, whose signing authority derives from a June 10, 2019 power of attorney originally executed in connection with a June 19, 2019 filing for Haymaker Acquisition Corp II. The agreement contains no assertions, forecasts, or operational data regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive personnel. Because it functions exclusively as an administrative grouping mechanism for regulatory transparency, it does not advance the SPAC’s search timeline, modify redemption windows, or signal new sponsorship activity, yet it provides a verifiable chain of custody for beneficial ownership reporting during the company’s active search phase.

What changed: Quarterly Report (Form 10-Q) for Evolution Global Acquisition Corp, a blank-check SPAC, for the quarter ended September 30, 2025. The Company consummated its IPO on November 12, 2025, after the balance sheet date. Key post-quarter mechanics: Gross proceeds of $240M (24M units at $10/unit), including full exercise of the 3M-unit over-allotment option. $240M placed in trust ($10.00 per public share). Simultaneous private placement of 6.8M warrants at $1/warrant ($6.8M gross, 4.4M to Sponsor, 2.4M to Cohen & Co.). On November 10, 2025, the Company issued 1,333,333 additional Class B ordinary shares to Sponsor, bringing total Founder Shares to 8,000,000 (1,000,000 previously subject to forfeiture are now permanent due to over-allotment exercise). Sponsor granted 1,958,333 Founder Shares to officers and directors (fair value $5,032,916 recorded as compensation expense). This filing is a pre-IPO quarterly report; the trust and public shares did not exist at the balance sheet date. Why it matters: This filing establishes the baseline pre-IPO financials and confirms the SPAC is capitalized with a 24-month completion window (deadline Nov. 2027). Investors can now track trust value ($240M at $10/share), working capital ($1.18M post-IPO), and the over-allotment closure. A significant stock-based compensation charge of $5M was recorded for officer/director grants. The management consulting agreement with an entity controlled by the CEO (Evolution Capital Pty Ltd) for $480,000 is a related-party item to monitor.

What changed: SEC Form 8-K current report under Item 5.02 disclosing the appointment of a new independent director. Gavin Apter was appointed as an independent director to the board of Evolution Global Acquisition Corp effective December 2, 2025. Per the filing, Mr. Apter assumes duties on the Audit Committee, the Nominating and Corporate Governance Committee, and the Compensation Committee, where he serves as Chairperson. The filing does not announce any amendments to the redemption calendar, trust account disbursement procedures, extension vote thresholds, target negotiation status, or sponsor governance commitments. XBRL security listings confirm existing warrants remain exercisable at $11.50 per share. Why it matters: Board appointments directly shape the sponsor’s acquisition funnel, due diligence rigor, and post-merger operating model. According to the filing, Mr. Apter founded Loyalsnap, Inc., a technology enterprise that, under his leadership since 2015, serves more than 5,000 fitness and wellness businesses globally as a CRM and automation platform. His prior professional trajectory, as detailed in the disclosure, spans Goldman Sachs roles from 2005 through 2013 across Sydney, Hong Kong, and New York, during which he supported investment banking clients on capital raising, M&A advisory, and strategic transactions in metals, mining, and energy, and subsequently advised pan-Asian and U.S.-based hedge funds on equities, commodities-linked exposures, and natural-resource capital deployment. Chief Executive Officer Stephen Silver stated the appointment brings capabilities "well aligned with the needs of listed exploration and natural resources companies." The filing contains no financial forecasts, customer aggregation data beyond the named platform count, intellectual property disclosures, contractual commitment levels, or active litigation references. For redemption-track investors, the substitution of an operator who has scaled a high-volume, membership-driven tech platform alongside deep institutional resource-sector finance suggests the sponsor may prioritize targets with recurring revenue architectures, scalable software infrastructure, or commodity-linked exposure, while also elevating audit and compensation oversight capacity ahead of any shareholder vote.

What changed: Form 3, an initial statement of beneficial ownership of securities filed under Section 16(a) of the Securities Exchange Act of 1934. According to the Form 3 filing, director Apter Gavin reported an indirect holding of 125,000 shares in Evolution Global Acquisition Corp. The SEC record confirms the SPAC remains in SEARCHING status, carries a trust value of $10.23 per share, and retains a business combination deadline of 2027-11-12. The filing discloses no acquisitions, dispositions, or option exercises, meaning the redemption window, trust account balance mechanics, and extension timeline remain unaltered by this submission. Why it matters: This compliance exhibit establishes baseline insider ownership for Apter Gavin ahead of any future de-SPAC transaction. Because the document lists only a static share quantity without transaction dates, purchase price, or financing commitments, it does not indicate active deal progress or shift sponsor alignment metrics. The filing contains no claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or executive conduct beyond the reported director name and share count. Investors should await subsequent merger announcements, preliminary proxy filings, or trust distribution notices for actionable updates on the 2027-11-12 deadline and shareholder redemption rights.

What changed: A Form 8-K current report attached to a press release announcing the mechanical separation and subsequent separate trading of the registrant’s publicly listed units, Class A ordinary shares, and redeemable warrants. The filing confirms that, commencing December 3, 2025, holders of EVOXU units may elect to separate them into tradable Class A ordinary shares and warrants by directing their brokers to contact Continental Stock Transfer & Trust Company. The company states its initial public offering closed on November 12, 2025. Each unit comprises one Class A ordinary share with a $0.0001 par value and one-half of one redeemable warrant exercisable at $11.50 per share. The document reports zero changes to the redemption deadline, the trust account valuation, extension protocols, target acquisition progress, or sponsor leadership. Unseparated units will continue trading as EVOXU, while separated shares and warrants trade as EVOX and EVOXW on the Nasdaq Global Market tier. Why it matters: While the unit-split administration does not modify investor redemption windows, trust distribution mechanics, or de-SPAC timelines, it dictates near-term liquidity structures for shareholders prior to any business combination vote. The attached press release reiterates the sponsor’s stated strategy to effect a merger, amalgamation, share exchange, or asset purchase with companies owning, operating, or developing assets in the critical minerals sector that support United States economic and national security interests. Underwriter attribution goes to Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC (lead book-running manager) and Clear Street LLC (co-manager). The filing was executed by Chief Executive Officer Stephen Silver and cross-references a prospectus declared effective with the SEC on July 14, 2025.

What changed: Routine compliance exhibit: a Joint Filing Agreement attached to a Schedule 13G beneficial ownership report. This document establishes a joint filing arrangement between Evolution Sponsor Holdings LLC and Stephen Silver for their combined holding of Evolution Global Acquisition Corp ordinary shares, par value $0.0001 per share, executed on November 24, 2025. Bearing on the specified investor mechanics—redemption deadlines, trust account valuation, extension voting, business combination progress, or sponsor conduct—the filing introduces zero changes. It contains only standard Exchange Act Rule 13d-1(k) language confirming that each signatory accepts independent responsibility for the timeliness, accuracy, and completeness of their own reporting information, while expressly disavowing liability for the other party’s data absent actual knowledge of inaccuracy. Why it matters: Investors monitoring the SPAC’s capital preservation trajectory, liquidation thresholds, or management catalysts receive no operational update from this exhibit. The filing discloses no claims regarding potential targets, customer agreements, revenue projections, market sizing, technology assets, partnership structures, litigation exposure, or executive team adjustments. By confirming only administrative SEC reporting compliance, it leaves the company’s pre-deal searching phase entirely unchanged, indicates no movement toward a redemption event or extension proposal, and provides no basis to adjust sponsorship conduct assessments.

What changed: A Form 8-K current report and accompanying audited balance sheet filed by Evolution Global Acquisition Corp. In its own terms, the filing serves as a disclosure of the consummation of the company’s initial public offering of 24,000,000 units and the simultaneous private placement of 6,800,000 warrants, accompanied by financial statements reflecting the transaction. The registrant reports that on November 12, 2025, it completed its IPO at $10.00 per unit, generating $240,000,000 in gross proceeds, including full exercise of a 3,000,000-unit over-allotment option. Simultaneously, the sponsor purchased 4,400,000 private warrants and Cohen & Company Capital Markets/Clear Street purchased 2,400,000 private warrants for $6,800,000 total. The registrant states that as of November 12, 2025, $240,000,000 was deposited into a U.S.-based trust account, with the filing noting the initial expectation was $10.00 per public share plus interest. The filing establishes a 24-month Completion Window from the IPO closing date to consummate a business combination, stating that time cannot be extended beyond 24 months without a shareholder vote. If an extension is approved, the company will offer public shareholders redemption rights at the pro-rata trust amount. The sponsor, Evolution Sponsor Holdings LLC, has agreed to waive redemption rights for its 8,000,000 founder shares, vote those shares in favor of a business combination, and remains liable to replenish the trust account if third-party claims reduce it below $10.00 per share. Cohen & Company Capital Markets has agreed to waive its $9,600,000 deferred underwriting commission if the business combination fails within the Completion Window. Warrants are exercisable at $11.50 per share, expiring five years post-combination, with a cash-call redemption trigger set at $18.00 per share. The company paid $15,036,813 in transaction costs, comprising $4,320,000 in cash underwriting fees, $9,600,000 in deferred fees, and $1,116,813 in other offering costs. Why it matters: This filing materializes the operational and financial baseline for all future redemption calendar tracking. It confirms the exact $240,000,000 trust balance and cements the November 12, 2027 deadline for a potential business combination, establishing the absolute latest redemption event absent a successfully voted extension. The sponsor’s wealth transfer disclosures provide immediate transparency into early-stage conduct: the company notes that on November 10, 2025, the sponsor granted membership interests equivalent to 1,958,333 founder shares to officers and directors for $8,421, resulting in $5,032,916 in compensation expense based on a $9.84 implied share price, 30.0% probability of de-SPAC, and a discount for lack of marketability of $0.38. Furthermore, the registrant states it paid a $480,000 advisory fee to Evolution Capital Pty Ltd, a managing member entity of the sponsor where Chief Executive Officer Stephen Silver is the managing member. Strategy-wise, the company explicitly states it has not commenced operations, holds no operating revenues, and has broad discretion to pursue targets across any industry or geographic region. It must acquire a target with an aggregate fair market value of at least 80% of the Trust Account value (excluding deferred underwriting commissions and taxes), and management has determined sufficient working capital exists to cover due diligence and negotiation costs through the 24-month window without raising additional funds. Underwriters have granted the founders and management a 180-day lock-up period, and the company engaged WithumSmith+Brown, PC as auditor since 2025. All terms define the mechanical floor for public shareholder liquidity and sponsor alignment ahead of any target announcement.